E. Argyropoulos

Restoration of Complement-Enhanced Neutralization of Vaccinia Virus Virions by Novel Monoclonal Antibodies Raised against the Vaccinia Virus Complement Control Protein

J. Lambris, G. Sfyroera, S. Isaacs, 2003, Journal of Virology.

Novel monoclonal antibodies against mouse C3 interfering with complement activation: description of fine specificity and applications to various immunoassays.

John D Lambris, S. Franchini, J. Lambris, 2004, Molecular immunology.

Kinetic Analysis of the Interactions of Complement Receptor 2 (CR2, CD21) with Its Ligands C3d, iC3b, and the EBV Glycoprotein gp350/2201

W. T. Moore, John D Lambris, S. Franchini, 2001, The Journal of Immunology.

Glycoprotein gp350/220 Its Ligands C3d, iC3b, and the EBV Complement Receptor 2 (CR2, CD21) with Kinetic Analysis of the Interactions of

W. T. Moore, S. Franchini, J. Lambris, 2001 .

Integrated computational and experimental approach for lead optimization and design of compstatin variants with improved activity.

Christodoulos A Floudas, Dimitrios Morikis, John D Lambris, 2003, Journal of the American Chemical Society.